Ell cytotoxicity and cytokine release by the drug glatiramer acetate. Cell. Mol. Life Sci. 2009, 66, 1446456. Al-Falahi, Y.; Sand, K.L.; Knudsen, E.; Damaj, B.B.; Rolin, J.; Maghazachi, A.A. Splenic organic killer cell activity in two models of experimental neurodegenerative ailments. J. Cell. Mol. Med. 2009, 13, 2693703. H lund, R.; Harbo, H.F.; Holm , T.; Maghazachi, A.A. A one year follow-up study of all-natural killer and dendritic cells activities in numerous sclerosis patients getting glatiramer acetate. PLoS 1 2013, eight, e62237. Hestvick, A.L.K. The Double-edged sword of autoimmunity: Lessons from various sclerosis. Toxins 2010, two, 85677. Ascherio, A.; Munger, K.L. Environmental threat aspects for multiple sclerosis. Part II: Noninfectious factors. Ann. Neurol. 2007, 61, 50413. Ascherio, A.; Munger, K.L.; Simon, K.C. Vitamin D and many sclerosis. Lancet Neurol. 2010, 9, 59912. Brustad, M.; Sandanger, T.; Aksnes, L.; Lund, E. Vitamin D status within a rural population of northern Norway with high fish liver consumption.Aprepitant-d4 Public Wellness Nutr. 2004, 7, 78389. Lemire, J.M.; Archer, D.C. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J. Clin. Investig. 1991, 87, 1103107. Cantorna, M.T.; Hayes, C.E.; DeLuca, H.F. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of many sclerosis.Pilocarpine Hydrochloride Proc. Natl. Acad. Sci. USA 1996, 93, 7861864. Burton, J.M.; Kimball, S.; Vieth, R.; Bar-Or, A.; Dosch, H.M.; Cheung, R.; Gagne, D.; D’Souza, C.; Ursell, M.; O’Connor, P. A phase I/II dose-escalation trial of vitamin D3 and calcium in numerous sclerosis. Neurology 2010, 74, 1852859. Smolders, J.; Thewissen, M.; Peelen, E.; Menheere, P.; Tervaert, J.W.; Damoiseaux, J.; Hupperts, R. Vitamin D status is positively correlated with regulatory T cell function in individuals with numerous sclerosis. PLoS 1 2009, four, e6635. Smolders, J.; Peelen, E.; Thewissen, M.; Tervaert, J.W.; Menheere, P.; Hupperts, R.; Damoiseaux, J. Security and T cell modulating effects of high hose vitamin D3 supplementation in a number of sclerosis. PLoS One 2010, 5, e15235.Toxins 2013,25. Wergeland, S.; Torkildsen, ; Myhr, K.M.; Aksnes, L.; M k, S.J.; B L. Dietary vitamin D3 supplements minimize demyelination inside the cuprizone model. PLoS 1 2011, six, e26262. 26. Brinkmann, V. Sphingosine 1-phosphate receptors in well being and disease: Mechanistic insights from gene deletion studies and reverse pharmacology.PMID:25016614 Pharmacol. Ther. 2007, 115, 8405. 27. Kveberg, L.; Bryceson, Y.; Inngjerdingen, M.; Rolstad, B.; Maghazachi, A.A. Sphingosine 1 phosphate induces the chemotaxis of human organic killer cells. Role for heterotrimeric G proteins and phosphoinositide 3 kinases. Eur. J. Immunol. 2002, 32, 1856864. 28. Lagadari, M.; Lehmann, K.; Ziemer, M.; Truta-Feles, K.; Berod, L.; Idzko, M.; Barz, D.; Kamradt, T.; Maghazachi, A.A.; Norgauer, J. Sphingosine-1-phosphate inhibits the cytotoxic activity of NK cells through Gs protein-mediated signaling. Int. J. Oncol. 2009, 34, 28788. 29. Rolin, J.; Sand, K.L.; Knudsen, E.; Maghazachi, A.A. FTY720 and SEW2871 reverse the inhibitory effect of S1P on organic killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine release. Cancer Immunol. Immnuother. 2010, 59, 57586. 30. Pandya, A.D.; Al-Jaderi, Z.; H lund, R.A.; Holm , T.; Harbo, H.F.; Norgauer, J.; Maghazachi, A.A. Identification of human NK17/NK1 cells. PLoS 1 2011, 6, e26780. 31. Godi.
